We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

5% more funds holding

Funds holding: 167 → 175 (+8)

4% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 57

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $1.01B → $899M (-$108M)

83% less call options, than puts

Call options by funds: $7.01M | Put options by funds: $40.8M

Holders
175
Holders Change
+8
Holders Change %
+4.79%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
59
Reduced
57
Closed
18
Calls
$7.01M
Puts
$40.8M
Net Calls
-$33.8M
Net Calls Change
-$26.8M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$14.3M
2
BFA
BlackRock Fund Advisors
California
+$12.4M
3
SCM
Scopia Capital Management
New York
+$6.5M
4
SM
Sabby Management
Florida
+$5.23M
5
Millennium Management
Millennium Management
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$13.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.44M
4
Goldman Sachs
Goldman Sachs
New York
-$7.54M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Canada Life
76
Canada Life
Manitoba, Canada
$1.12M -$42.8K -18 -4%
New York State Teachers Retirement System (NYSTRS)
77
New York State Teachers Retirement System (NYSTRS)
New York
$1.11M – – –
Barclays
78
Barclays
United Kingdom
$1.1M -$730K -307 -39%
Russell Investments Group
79
Russell Investments Group
United Kingdom
$1.09M +$1.18M +497 New
Comerica Bank
80
Comerica Bank
Texas
$1.05M +$49.9K +21 +5%
Simplex Trading
81
Simplex Trading
Illinois
$1.03M +$922K +388 +562%
Wells Fargo
82
Wells Fargo
California
$1.02M -$152K -64 -12%
MCC
83
Malaga Cove Capital
California
$971K -$49.9K -21 -5%
PPA
84
Parametric Portfolio Associates
Washington
$958K +$11.9K +5 +1%
SI
85
Scout Investments
Missouri
$915K -$514K -216 -35%
New York State Common Retirement Fund
86
New York State Common Retirement Fund
New York
$884K – – –
CAM
87
ClariVest Asset Management
California
$880K -$2.38K -1 -0.3%
FP
88
Foundry Partners
Minnesota
$877K +$925K +389 New
VEA
89
Virtus ETF Advisers
New York
$850K +$418K +176 +88%
ARTA
90
A.R.T. Advisors
New York
$842K +$887K +373 New
AA
91
ALPS Advisors
Colorado
$833K -$288K -121 -25%
UBS Group
92
UBS Group
Switzerland
$818K +$447K +188 +108%
QIM
93
Quantitative Investment Management
Virginia
$767K +$808K +340 New
Massachusetts Financial Services
94
Massachusetts Financial Services
Massachusetts
$762K +$262K +110 +48%
Citadel Advisors
95
Citadel Advisors
Florida
$737K -$10.8M -4,544 -93%
PP
96
Paloma Partners
Connecticut
$729K +$342K +144 +80%
ProShare Advisors
97
ProShare Advisors
Maryland
$722K +$83.2K +35 +12%
Squarepoint
98
Squarepoint
New York
$717K +$756K +318 New
State Board of Administration of Florida Retirement System
99
State Board of Administration of Florida Retirement System
Florida
$696K – – –
AA
100
AlphaMark Advisors
Kentucky
$691K – – –
2 3
4
5 6

ACOR Hedge Fund Activity: Q4 2016 in Review

175 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2016, worth a combined $899M — down 11% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 18 closed out — a net gain of 10 holders — while 59 added to existing stakes and 57 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $14.3M. The largest seller was Eagle Asset Management, cutting an estimated $13.7M.

  • 175 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2016, up from 167 in Q3 2016.
  • Funds reported $899M of Acorda Therapeutics stock for Q4 2016, down 11% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q4 2016 and 18 closed out, a net change of +10 holders.
  • The largest Acorda Therapeutics buyer in Q4 2016 was Perceptive Advisors, an estimated $14.3M added.
  • The largest Acorda Therapeutics seller in Q4 2016 was Eagle Asset Management, an estimated $13.7M sold.

Based on aggregated 13F filings for Q4 2016.